These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28986190)

  • 21. Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
    Miyake N; Chong Y; Nishida R; Takenaka K; Kato K; Miyamoto T; Aono A; Takaki A; Mitarai S; Shimoda S; Shimono N; Akashi K
    J Infect Chemother; 2018 Jan; 24(1):78-81. PubMed ID: 28988958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.
    Rowe RG; Guo D; Lee M; Margossian S; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1275-1283. PubMed ID: 27090959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
    Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
    Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.
    Kang JY; Ha JH; Kang HS; Yoon HK; Kim HJ; Lee S; Lee DG; Jung JI; Kim SC; Kim YK
    Int J Hematol; 2015 May; 101(5):505-13. PubMed ID: 25663510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Characteristics of Non-tuberculous Mycobacteria (NTM) Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-analysis.
    Cinicola BL; Ottaviano G; Hashim IF; Zainudeen ZT; Hamid IJA; Elfeky R
    J Clin Immunol; 2023 Dec; 44(1):23. PubMed ID: 38129624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
    Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.
    Wu JL; Ma HY; Lu CY; Chen JM; Lee PI; Jou ST; Yang YL; Chang HH; Lu MY; Chang LY; Huang LM
    J Microbiol Immunol Infect; 2017 Jun; 50(3):307-313. PubMed ID: 26346369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.
    Camargo JF; Kimble E; Rosa R; Shimose LA; Bueno MX; Jeyakumar N; Morris MI; Abbo LM; Simkins J; Alencar MC; Benjamin C; Wieder E; Jimenez A; Beitinjaneh A; Goodman M; Byrnes JJ; Lekakis LJ; Pereira D; Komanduri KV
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):806-814. PubMed ID: 29217388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study.
    Longworth SA; Vinnard C; Lee I; Sims KD; Barton TD; Blumberg EA
    Transpl Infect Dis; 2014 Feb; 16(1):76-83. PubMed ID: 24350627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
    Cohen L; Yeshurun M; Shpilberg O; Ram R
    Transpl Infect Dis; 2015 Aug; 17(4):510-7. PubMed ID: 25940504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus viremia is associated with poor outcomes in AIDS patients with disseminated nontuberculous mycobacterial disease.
    Tian B; Sun J; Bai J; Zhang R; Liu J; Shen Y; Li C; Liu L; Chen J; Qi T; Lu H
    Biosci Trends; 2022 Jan; 15(6):406-412. PubMed ID: 34588390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.
    Doucette K; Fishman JA
    Clin Infect Dis; 2004 May; 38(10):1428-39. PubMed ID: 15156482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
    PLoS One; 2017; 12(9):e0185210. PubMed ID: 28934311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated Mycobacterium kansasii infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Sekiguchi E; Kurosawa S; Iketani Y; Yoshimura Y; Nakazato T
    Int J Infect Dis; 2024 Sep; 146():107123. PubMed ID: 38838847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.
    Rustia E; Violago L; Jin Z; Foca MD; Kahn JM; Arnold S; Sosna J; Bhatia M; Kung AL; George D; Garvin JH; Satwani P
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1646-1653. PubMed ID: 27252110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.